Our Bond, Inc. Total Cost of Revenue increased by 5.7% to $2.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.7%, from $2.18M to $2.30M. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $2.26M | $2.26M | $2.26M | $2.26M | $2.18M | $2.30M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -3.6% | +5.7% |
| YoY Change | — | — | — | — | -3.6% | +5.7% |